Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06758609Completed
Randomised, open-label trial in ischemic stroke (2 arms), sponsored by Guangdong Second Provincial General Hospital. Primary endpoint: Proportion of patients with modified Rankin Score 0-2 at 90 days. Started Jan 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06758609.